top of page

Search Results

Results found for "GPCR-RAMP interactions"

  • From One to Many: How a GPCR Curiosity Became a Field-Wide Toolkit

    Tom Sakmar didn’t set out to map GPCR-RAMP interactions across hundreds of receptors. , multiplexed platform to investigate GPCR-RAMP biology  like never before. and an online platform to query GPCR-RAMP interaction data and antibody validations. & orphan GPCRs Identify new accessory protein interactions Build disease-relevant signaling models Validate interactions , Family B GPCRs , GPCR scientist network , GPCR data platform , Dr.

  • Dr. GPCR Updates

    GPCR – Precision Tools for GPCR Assays Dr. GPCR and Celtarys Research have teamed up. features a discussion about a scalable GPCR-RAMP assay. Their global resource is now helping labs decode GPCR biology at scale. It’s exciting to see how the GPCR field is evolving. GPCR Team

  • Dr. GPCR and GeneTex Partner to Engage the Community on Anti-GPCR Antibody Challenges

    GPCR, a nonprofit organization serving the global G protein-coupled receptor (GPCR) research community research and GPCR drug discovery. GPCR. GPCR Dr. GPCR supports scientists and organizations advancing GPCR biology and GPCR-targeted drug discovery.

  • Dr. GPCR and Eurofins DiscoverX Join Forces to Accelerate GPCR Drug Discovery

    GPCR , the global knowledge hub for G protein-coupled receptor (GPCR) research and education, today announced Their cell-based assays support a wide range of mechanisms of action, including cAMP accumulation, β-arrestin GPCR . GPCR Dr. GPCR empowers scientists and organizations advancing GPCR biology and GPCR-targeted drug discovery.

  • GPCR Happy Hour Boston 2026 — April 29 | Dr. GPCR Community Event

    Some of the best conversations in GPCR science don't happen at the podium. That's why we created GPCR Happy Hour. On April 29th, the Dr. GPCR community is gathering in Boston for an informal evening of real conversation. Who's making the GPCR Happy Hour evening possible GPCR Happy Hour is made possible by four companies The first company to offer access to recombinant GPCR assays.

  • Inside Out: Mapping GPCRs from Membrane Codes to Market Moves

    Hi GPCR Enthusiasts (and Arrestin Aficionados!)   This week at Dr. of GPCR-RAMP discovery. GPCR Updates   Advanced Methods for the Optimization of Candidate Selection  – Master GPCR behavior beyond Ilana Kotliar share how three decades of curiosity evolved into a tech-powered platform for mapping GPCR-RAMP interactions.

  • Accelerating GPCR Drug Discovery

    But your GPCR program still isn't moving at the pace it should. The GPCR Data Dilemma: The Lego Bucket Problem I've seen promising GPCR programs generate massive volumes GPCR As the co-founder of Dr. GPCR, we've built a global hub connecting over 1,300 GPCR scientists dedicated to this field. Ready to Move Your GPCR Program Forward?

  • GPCR Selectivity Beyond the Receptor

    functions as a PAM-agonist for arrestin while modulating G protein selectivity through simultaneous interactions Examples spanning GPCR families A, B, and T suggest that interface-directed modulation may represent P2Y14, activated by UDP-sugars as a DAMP receptor, is targeted through antagonism. GPCR Course Attendee About Dr. GPCR Dr. GPCR is the intelligence and community platform for GPCR scientists.

  • Fluorescence Polarization in GPCR Research

    The ability to identify compounds that interact with molecular targets involved in disease pathways is This technique is most effective at studying interactions between large proteins and small ligands thanks Compatible with various sources of GPCRs. Contact us  to drive further advancements in GPCR drug discovery!   Exploring Non-orthosteric Interactions with a Series of Potent and Selective A3 Antagonists.

  • Understanding Biased Signaling in GPCRs

    through ligands that stabilize receptor conformations and favor selective transducer interactions. SBI-553 functions as a PAM-agonist for arrestin while modulating G protein engagement through direct interaction are often treated as complementary readouts of the same interaction. inverse agonists that bind an induced intracellular allosteric pocket, disrupting receptor–G protein interactions GPCR Dr.

  • Five GPCR Masterclasses Before The Summer

    Sam Hoare  — How Signaling Kinetics Shapes GPCR Drug Action. May 14. Sudarshan Rajagopal  — The Spatiotemporal Revolution in GPCR Biology. May 21. Andrew Tobin  — How to Build Breakthrough GPCR Programs. June 4. GPCR community gathers in person next week. GPCRs Targeted Drug Discovery Summit  — April 28–30. GPCR Dr. GPCR is the intelligence and community for GPCR scientists.

  • Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery

    Recognizing, predicting, and leveraging these interactions is the essence of enzyme inhibition pharmacology This lesson reframes enzyme interaction not as background noise, but as a core pharmacological event. And responsible for countless drug–drug interactions. When Inhibition Becomes Activation Not all enzyme interactions are suppressive. Kenakin with your own enzyme or GPCR interaction puzzles.

  • GPCR Collaboration: From Models to Medicine

    That perspective changed the moment he entered GPCR research . : training the next generation of GPCR scientists . The GPCR Challenge What makes collaboration non-negotiable in GPCR research is the biology itself. GPCR Models Don’t Discover Drugs—People Do In GPCR research, the biggest breakthroughs won’t come from GPCR Podcast 🌱 Build a career with purpose, not just papers The Dr.

  • Advantages of Fluorescent Probes in GPCR Assays

    as they can be used to determine receptor activation dynamics, ligand binding geometry and receptor interactions This means fluorescent probes enable a dynamic observation of GPCRs. common starting point for employing fluorescent probes in GPCR assays. Fluorescent ligands: Bringing light to emerging GPCR paradigms. Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors.

  • From GPCR Data Chaos to Decisive Action

    Is Your GPCR Program Slowing Down—Even With Good Data? You’re not alone. GPCR Ecosystem. Strong science. Promising data. But no systems to turn it into momentum. GPCR, I’m connected to 1,300+ scientists and decision-makers worldwide. Who I Work With ✅ Biotech Teams  – Especially those lacking in-house GPCR leads or overwhelmed by CRO data chaos. ✅ Venture Capital Firms  – Looking to accelerate, troubleshoot, or validate GPCR assets

  • GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions

    GPCRs are present in a range of conformations, and the binding of a ligand, as well as interactions with GPCR targeting drugs: orthosteric vs allosteric sites Most of the drugs targeting GPCRs bind to the orthosteric GPCRs functional selectivity Recent research has revealed a more intricate understanding of GPCR behavior Depending on the specific functional outcome measured (e.g. activation, interaction with accessory proteins selectively activate specific cellular outcomes linked to that GPCR.

  • Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs

    GPCR University Masterclass — Integrated GPCR Discovery in Practice Dr. GPCR Masterclass ➤ Eurofins DiscoverX Partnership — Tools and Insight for GPCR Drug Discovery Modern Their capabilities span cAMP, β-arrestin recruitment, receptor internalization, calcium flux, ligand GPCR Premium Membership Gives You an Edge GPCR drug discovery is accelerating — across obesity, CNS, GPCR operates as a membership-based, nonprofit initiative — built to strengthen the GPCR field through

  • GPCR Happy Hour – Boston, Sept 2025

    That’s exactly why we created GPCR Happy Hour . GPCR’s nonprofit mission to unite and empower the GPCR community worldwide FOMO is real: if you’re not Be Part of the GPCR Community Dr. GPCR is a nonprofit global community  dedicated to building a strong, connected GPCR ecosystem. GPCR Happy Hour is more than a social event.

  • Understanding Enzyme Inhibition In GPCR Discovery Programs

    mutated GPCRs. Plus: top tracks to watch at GPCR Forum 2025, fresh postdoc openings at the ADME/signaling interface , and concise reads on β-agonists, phospho-barcodes, and GPCR allostery. Mastering inhibition isn’t just about avoiding drug–drug interactions. The pace of GPCR innovation is accelerating.

  • How Collaboration Drives GPCR Discoveries

    GPCR signaling wasn’t linear. It wasn’t clean. And interactions with GLP-1 pathways were inconsistent. The protein was interacting with GPCRs in a way that no single technique could reveal. Why GPCR Collaboration Is Essential for Modern Science Hodson makes the point bluntly: modern GPCR science Together, they push GPCR science faster.

  • The Truth About GPCR Product Launches: Years in the Making

    GPCR and Revvity. But there was a pivot: the tech had untapped potential for GPCRs. Why This Matters: The GPCR toolkit scientists use today—cAMP, IP-One, and now pHSense—didn’t evolve incrementally GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr. GPCR Premium Ecosystem  for behind-the-scenes access to GPCR innovators, exclusive deep-dives, and practical

  • Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon

    space focused on GPCR pharmacology. – GPCR mutations in cancer—drivers, passengers, or both?  GPCR Updates Learn Pharmacology That Drives Discovery  – From Dr. GPCR Podcast appearance. GPCR Team

  • How System-Level GPCR Thinking Prevents Discovery Failures

    Upcoming events:  Adhesion GPCR Workshop; GRC—Transporters, Ion Channels & GPCRs; MPGPCR Joint Satellite GPCR Podcast: Chemical Probes for GPCR Imaging with Dr. GPCR Premium Membership Gives You an Edge Premium gives GPCR scientists and biotech teams a single, trusted GPCR and the offered resources in my work sphere." GPCR research and education across the global community.

  • GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery

    s latest lecture delivers high-impact insight crafted for teams navigating the complex behaviors of GPCR-targeting As Kenakin explains, all GPCR signaling is allosteric , and pretending otherwise introduces risk at every probe dependence : the idea that the effect of an allosteric modulator depends entirely on the probe it interacts But without understanding how GPCR state changes  influence that affinity—or vice versa—drug discovery Corner  is your trusted, expert-led guide through the evolving landscape of GPCR science.

  • Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026

    Must-read publications:  GPCRs in neurological disorders; OSTα-OSTβ structure; GPCR–G protein–β-arrestin GPCR podcast , Dr. Martin Marro shares hard-earned lessons from the interface of assays, bias, and translation. GPCR innovation is accelerating. GPCR Team

  • Your GPCR Program Decisions Depend on Good Data Interpretation

    Welcome GPCR Fans,   In GPCR-targeted drug discovery, precision isn’t optional—it’s a requirement. GPCR Premium Members this week gain curated, early access to: Industry insights : GPCRs and mRNA in drug The interpretation of high and low affinity binding sites on GPCRs. GPCR Premium Membership Gives You an Edge Dr. GPCR Premium gives you an edge in a fast-moving field.

  • Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies

    The central role of GPCRs in Neurological Disorders GPCRs are the largest family of membrane receptors Over 30% of FDA-approved drugs target GPCRs, with many targeting CNS located GPCRs. They manage this by interacting with G-proteins. What happens when a GPCR is activated? Depending on the type of GPCR, it can lead to different secondary messengers , like cAMP, IP3, which Some of the advantages of using fluorescent ligands for this are: Live-cell imaging:  receptor-ligand interactions

  • Allosteric Binding Demystified: Smarter GPCR Drug Discovery

    Hello GPCR Enthusiasts, Interpreting binding data isn’t optional—it’s career-defining. GPCR Premium: Sneak Peek Every week, Premium Members get curated intelligence they won’t find in open Read the article now ➤ Discovery on Target - The Next Wave of GPCR Drug Discovery The 20th Annual GPCR-Based GPCR Premium Membership Gives You an Edge The GPCR field is advancing at breakneck speed. The pace of GPCR innovation is accelerating.

  • Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024

    Get your space suits on, GPCR cadets! up with a series of cosmic GPCR events for the year ahead. Discounted GPCR courses - because who doesn't love a good deal?  From 2025, only Premium Members will have access to Classified GPCR News. Classified GPCR News  Let’s dive into the   Classified GPCR News from October 28th to November 3rd, 2024

  • Better GPCR Drug Discovery Decisions Start With Structured Learning

    If you work in GPCR research, clarity is leverage. Upcoming events: 12th Adhesion GPCR Workshop; GPCRnet International Symposium; 5th GPCRs Targeted Drug GPCR University has undergone a structural redesign. Assess hepatotoxicity risk—anticipate reactive metabolites and high-risk drug–drug interactions. GPCR Premium Membership Gives You an Edge GPCR science is accelerating across obesity, CNS, oncology,

bottom of page